These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35643251)

  • 1. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
    Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
    Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
    Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
    Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
    Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of primary tumor location with long-term oncological prognosis following hepatectomy for hepatocellular carcinoma:A multicenter propensity score matching analysis.
    Tang SC; Lin KY; Huang TF; Zhang KL; Kong J; He XL; Luo C; Chen QJ; Guo PF; Zhou WP; Zeng YY
    Eur J Surg Oncol; 2023 Jul; 49(7):1234-1241. PubMed ID: 36774217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
    Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
    Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
    Tang SC; Zhang KL; Lin KY; Tang YD; Fu J; Zhou WP; Zhang JX; Kong J; He XL; Sun ZH; Luo C; Liu HZ; Lai YP; Zeng YY
    Hepatol Int; 2024 Apr; 18(2):623-635. PubMed ID: 37880566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study.
    Long L; Chen B; Wang H; Zhao Y; Wu F; Wang L; Rong W; Wu J; Li Y; Wang W
    Radiother Oncol; 2023 Mar; 180():109462. PubMed ID: 36634853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
    Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
    BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study.
    Zhu RH; Huang Z; Xie ZH; Yuan T; Li J; Wang WQ; Lv X; Wang JL; Huang ZY; Zhang EL
    Asian J Surg; 2024 Jul; 47(7):3007-3014. PubMed ID: 38342723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C; Gao R; Guo S; Ning C; Li A; Wang X; Li S; Ding J; Kong X; Wang Q; Xu Y; Li J; Gao J; Wang S; Kong J; Ke S; Sun W
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.
    Michelakos T; Kontos F; Sekigami Y; Qadan M; Cai L; Catalano O; Deshpande V; Patel MS; Yamada T; Elias N; Dageforde LA; Kimura S; Kawai T; Tanabe KK; Markmann JF; Yeh H; Ferrone CR
    J Gastrointest Surg; 2021 Jul; 25(7):1727-1735. PubMed ID: 32779082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
    Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
    Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
    Chen B; Wu JX; Cheng SH; Wang LM; Rong WQ; Wu F; Wang SL; Jin J; Liu YP; Song YW; Ren H; Fang H; Tang Y; Li N; Li YX; Wang WH
    Hepatology; 2021 Nov; 74(5):2595-2604. PubMed ID: 34097307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis.
    Danzeng A; Guo L; Yang ZH; He ZW; Zeng CL; Ciren P; Lan RH; Jiang XW; Wang C; Zhang BH
    J Gastrointest Surg; 2024 Jul; 28(7):1104-1112. PubMed ID: 38723996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.